DHR - Danaher Corporation

NYSE - NYSE Delayed Price. Currency in USD
141.61
-1.39 (-0.97%)
At close: 4:02PM EDT
Stock chart is not supported by your current browser
Previous Close143.00
Open143.50
Bid141.35 x 900
Ask141.63 x 1000
Day's Range141.43 - 143.70
52 Week Range94.59 - 145.50
Volume3,626,129
Avg. Volume2,325,868
Market Cap101.383B
Beta (3Y Monthly)0.85
PE Ratio (TTM)41.47
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.68 (0.48%)
Ex-Dividend Date2019-06-27
1y Target EstN/A
Trade prices are not sourced from all markets
All
News
Press Releases
  • PR Newswire3 days ago

    Danaher Reports Second Quarter 2019 Results

    WASHINGTON , July 18, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the second quarter 2019. For the quarter ended June 28, 2019 , net earnings were $731.3 million , ...

  • ACCESSWIRE3 days ago

    Danaher Corp. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / July 18, 2019 / Danaher Corp. (NYSE: DHR ) will be discussing their earnings results in their 2019 Second Quarter Earnings to be held on July 18, 2019 at 8:00 AM Eastern Time. ...

  • PR Newswire24 days ago

    Danaher Announces New Dental Company To Be Named Envista Holdings Corporation

    WASHINGTON, June 27, 2019 /PRNewswire/ -- Danaher Corporation (DHR) ("Danaher") today announced that Envista Holdings Corporation ("Envista" or the "Company") will be the name of the separate company Danaher intends to create and take public via an initial public offering in the second half of 2019.  Envista will be comprised of three operating companies within Danaher's Dental segment: Nobel Biocare Systems, KaVo Kerr, and Ormco.

  • PR Newswirelast month

    Danaher Schedules Second Quarter 2019 Earnings Conference Call

    WASHINGTON, June 18, 2019 /PRNewswire/ -- Danaher Corporation (DHR) announced today that it will webcast its quarterly earnings conference call for the second quarter 2019 on Thursday, July 18, 2019 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the "Investors" section of Danaher's website, www.danaher.com, under the subheading "Events & Presentations." A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available until the next quarterly earnings call. You can access the conference call by dialing 866-503-8675 within the U.S. or +1 786-815-8792 outside the U.S. a few minutes before 8:00 a.m. ET and notifying the operator that you are dialing in for Danaher's earnings conference call (access code 8699843).

  • PR Newswire2 months ago

    Danaher To Present At Bernstein Strategic Decisions Conference

    WASHINGTON , May 23, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr. , will be presenting at the Bernstein Strategic Decisions ...

  • PR Newswire2 months ago

    Danaher to Present at Bank of America Merrill Lynch Health Care Conference

    WASHINGTON , May 8, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Matt McGrew , and Executive Vice President, Rainer Blair , ...

  • PR Newswire2 months ago

    Danaher Announces Quarterly Dividend

    WASHINGTON , May 7, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.17 per share of its common stock, ...

  • PR Newswire3 months ago

    Danaher Reports First Quarter 2019 Results

    WASHINGTON , April 18, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the first quarter 2019. For the quarter ended March 29, 2019 , net earnings were $333.8 million , ...

  • PR Newswire4 months ago

    Danaher Schedules First Quarter 2019 Earnings Conference Call

    WASHINGTON, March 19, 2019 /PRNewswire/ --Danaher Corporation (DHR) announced today that it will webcast its quarterly earnings conference call for the first quarter 2019 on Thursday, April 18, 2019 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the "Investors" section of Danaher's website, www.danaher.com, under the subheading "Events & Presentations." A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available until the next quarterly earnings call. You can access the conference call by dialing 866-503-8675 within the U.S. or +1 786-815-8792 outside the U.S. a few minutes before 8:00 a.m. ET and notifying the operator that you are dialing in for Danaher's earnings conference call (access code 1492175).

  • GlobeNewswire5 months ago

    Report: Developing Opportunities within Sarepta Therapeutics, Sally Beauty, Danaher, Ellie Mae, BioCryst Pharmaceuticals, and Akcea Therapeutics — Future Expectations, Projections Moving into 2019

    NEW YORK, March 06, 2019 -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders,.

  • PR Newswire5 months ago

    Danaher Announces Closing Of Common Stock Offering And Mandatory Convertible Preferred Stock Offering

    WASHINGTON, March 1, 2019 /PRNewswire/ -- Danaher Corporation (DHR) ("Danaher") announced today that it has closed concurrent offerings of 12,100,000 shares of common stock at a price to the public of $123.00 per share and 1,650,000 shares of 4.75% Series A Mandatory Convertible Preferred Stock at a price to the public of $1,000 per share (the offerings). The amounts sold include 1,100,000 shares of common stock and 150,000 shares of Mandatory Convertible Preferred Stock issued pursuant to the exercise in full of the separate options granted to the underwriters in each of the respective offerings to purchase additional shares.

  • PR Newswire5 months ago

    Danaher Announces Pricing Of Common Stock Offering And Mandatory Convertible Preferred Stock Offering

    WASHINGTON, Feb. 26, 2019 /PRNewswire/ -- Danaher Corporation (DHR) ("Danaher") announced today that it has priced concurrent offerings of 11,000,000 shares of common stock at a price to the public of $123.00 per share and 1,500,000 shares of 4.75% Series A Mandatory Convertible Preferred Stock at a price to the public of $1,000 per share (the offerings). The underwriters have separate 30-day options to purchase up to an additional 1,100,000 shares of common stock, and up to an additional 150,000 shares of mandatory convertible preferred stock.  The offerings are scheduled to be completed on March 1, 2019, subject to customary closing conditions.

  • PR Newswire5 months ago

    Danaher Announces Offerings Of Common Stock And Mandatory Convertible Preferred Stock

    WASHINGTON, Feb. 25, 2019 /PRNewswire/ -- Danaher Corporation (DHR) ("Danaher") announced today that it has commenced concurrent offerings of $1.35 billion of shares of common stock and $1.35 billion of shares of Series A Mandatory Convertible Preferred Stock, subject to market and other conditions (the offerings). Danaher expects to grant the underwriters separate 30-day options to purchase up to an additional $135 million of shares of common stock, and up to an additional $135 million of shares of mandatory convertible preferred stock. Danaher intends to use the net proceeds from the offerings to fund a portion of the purchase price of its pending acquisition of the Biopharma business of GE Life Sciences and to pay related fees and expenses.

  • PR Newswire5 months ago

    Danaher to Acquire the Biopharma Business of General Electric Life Sciences for $21.4 Billion

    WASHINGTON, Feb. 25, 2019 /PRNewswire/ -- Danaher Corporation (DHR) ("Danaher" or the "Company") announced today that it has entered into a definitive agreement with General Electric Company ("GE") (GE) to acquire the Biopharma business of GE Life Sciences ("GE Biopharma") for a cash purchase price of approximately $21.4 billion. Given anticipated tax benefits from the transaction structure, the net purchase price is approximately $20 billion. This represents a multiple of approximately 17 times expected 2019 EBITDA for GE Biopharma.

  • PR Newswire5 months ago

    Danaher To Present At Barclays Industrial Select Conference

    WASHINGTON , Feb. 13, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Matt McGrew , and Executive Vice President, Joakim Weidemanis ...

  • GlobeNewswire6 months ago

    Investor Expectations to Drive Momentum within E*TRADE Financial, Alliant Energy, DENTSPLY SIRONA, Danaher, Aspen Technology, and Marin Software — Discovering Underlying Factors of Influence

    NEW YORK, Jan. 31, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.

  • PR Newswire6 months ago

    Danaher Reports Fourth Quarter And Full Year 2018 Results

    WASHINGTON , Jan. 29, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the fourth quarter and full year 2018. For the quarter ended December 31, 2018 , net earnings were ...

  • PR Newswire6 months ago

    Danaher CEO To Comment On Financial Performance

    WASHINGTON, Jan. 7, 2019 /PRNewswire/ -- Danaher Corporation (DHR) (the "Company") announced that its President and Chief Executive Officer, Thomas P. Joyce, Jr., will comment tomorrow on the Company's fourth quarter 2018 performance in a presentation at the J.P. Morgan Healthcare Conference in San Francisco, California at 8:00 a.m. PT. Mr. Joyce will communicate that fourth quarter 2018 core revenue growth is expected to be above the Company's previously announced guidance and adjusted diluted net earnings per share is expected to be at or near the high-end of the Company's previously announced guidance. As previously announced, Danaher will hold its quarterly earnings conference call for the fourth quarter and year-end 2018 on Tuesday, January 29, 2019 at 8:00 a.m. ET.

  • PR Newswire7 months ago

    Danaher To Present At J.P. Morgan Healthcare Conference

    WASHINGTON , Jan. 2, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr. , will be presenting at the J.P. Morgan Healthcare Conference ...

  • PR Newswire7 months ago

    Danaher Schedules Fourth Quarter 2018 Earnings Conference Call

    WASHINGTON, Dec. 27, 2018 /PRNewswire/ -- Danaher Corporation (DHR) announced today that it will webcast its quarterly earnings conference call for the fourth quarter 2018 on Tuesday, January 29, 2019 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the "Investors" section of Danaher's website, www.danaher.com, under the subheading "Events & Presentations." A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available until the next quarterly earnings call. You can access the conference call by dialing 866-503-8675 within the U.S. or +1 786-815-8792 outside the U.S. a few minutes before 8:00 a.m. ET and notifying the operator that you are dialing in for Danaher's earnings conference call (access code 5756349).

  • PR Newswire7 months ago

    Danaher Initiates 2019 Outlook

    WASHINGTON, Dec. 13, 2018 /PRNewswire/ -- Ahead of its annual investor and analyst meeting to be held in New York City, Danaher Corporation (DHR) (the "Company") initiated its 2019 outlook. The Company anticipates that 2019 diluted net earnings per share will be in the range of $4.02 to $4.12. 2019 non-GAAP adjusted diluted net earnings per share is anticipated to be in the range of $4.75 to $4.85, which assumes non-GAAP core revenue growth of approximately 4%.

  • GlobeNewswire7 months ago

    Recent Analysis Shows American Express, Ryanair, Chubb, CNA Financial, Danaher, and Randgold Resources Market Influences — Renewed Outlook, Key Drivers of Growth

    NEW YORK, Dec. 06, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.

  • PR Newswire8 months ago

    Danaher To Webcast Investor And Analyst Meeting

    WASHINGTON, Nov. 13, 2018 /PRNewswire/ -- Danaher Corporation (DHR) will host a live video webcast of its Investor and Analyst Meeting in New York City on December 13, 2018 beginning at 9:30 a.m. ET. Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. With more than 20 operating companies, Danaher's globally diverse team of approximately 67,000 associates is united by a common culture and operating system, the Danaher Business System.